1. The Problem: 'Playing AI' Does Not Capture the Full Picture

Game AI research has a long history. Chess, Go, Atari, StarCraft. Each milestone demonstrated that machines could match or exceed human performance in well-defined competitive settings. But these achievements concentrated on a single axis: AI playing games. The broader ecosystem of game development, from concept to release to live operations, involves far more than play.

Meanwhile, foundation models and learned world models have rapidly expanded where AI fits in the game lifecycle. Predicting player behavior, generating level designs, automating test suites, adapting difficulty in real time. The problem is that these directions have evolved largely in isolation from one another. Individual research groups publish advances within their own domain, but it remains unclear which techniques transfer to other games or roles and which are locked to a specific engine, control scheme, or player population.

2. The Proposal: Six Roles Organized by AI Output

The authors define six roles based on how AI output is used: playing and acting; modeling players and games; designing games; building and maintaining games; generating and adapting at runtime; and testing and evaluating games. The organizing principle is not the AI technique itself but the purpose the output serves in the game lifecycle.

For each role, they examine four dimensions: what structure the game or workflow provides to the AI, what the AI learns or produces, which capabilities and artifacts transfer across settings, and what evidence supports the claims made in the literature. This four-question framework is applied consistently, making it possible to compare maturity across roles.

3. What the Abstract Reports

The authors identify cross-role connections. Agent trajectories train world models. Learned environments provide experience for agents. Design specifications drive executable implementations. Play and test feedback guides revision.

At the same time, they note that control schemes, rules, engine interfaces, state representations, and player contexts often remain setting-specific. Claims about performance in one setting require re-validation in the target setting.

Evaluation is most standardized for bounded game-playing and selected learned environments. Persistent state in learned worlds, repeated software revision, validated player modeling, sustained runtime adaptation, and representative automated testing remain less established.

This paper is a preprint and has not undergone peer review.

4. A Concrete Example: Automated Game Testing and Drug Trial Simulation

Automated Game Testing

After adding a new level, an AI agent plays through it to detect bugs or balance failures. But that agent is trained on a specific game's control scheme and cannot be dropped into a different game without retraining and re-validation.

Drug Trial Simulation

During trial design, a model generates virtual patient populations to test whether the trial protocol is sound. But that model depends on a specific disease area and patient population and cannot be reused for a different indication without re-validation.

Both cases share the same underlying challenge: artifacts trained in one context require re-verification when moved to another. The transferability barrier the survey identifies is not unique to games.

5. What Is Not New, and Where the Limits Are

Game AI surveys have been published before. What distinguishes this one is its focus on the foundation-model era and the six-role taxonomy. However, a survey does not report new findings; it draws a map of existing work. The map's accuracy depends on which papers were included and how the organizing axes were chosen. Any taxonomy imposes boundaries, and papers that straddle multiple roles may be forced into a single category.

From the abstract alone, it is not clear whether the authors provide quantitative criteria for transferability or whether the assessment of 'what is game-specific' rests on qualitative discussion. The depth of coverage within each role is also not described in the abstract. A survey that spans six roles risks trading depth for breadth, and readers interested in a specific role may find the coverage insufficient compared to a focused review.

The abstract acknowledges that evaluation standards vary widely across roles. This is an honest admission, but it also means the survey's conclusions about maturity are, by necessity, uneven in their evidentiary basis.

6. Why This Topic Is Drawing Attention Now

The survey has received 113 upvotes on Hugging Face and 176 stars on GitHub. These are indicators of community interest, not measures of correctness or significance.

The attention likely reflects the rapid expansion of foundation-model applications in the game industry. Text-to-game-world generation, real-time player behavior prediction, AI-driven test automation: individual research threads are accelerating, but few publications have attempted to map the whole landscape. This survey drew interest because it offers a single framework for viewing scattered work.

7. What This Connects to in Pharma and Regulatory Work

Games and pharmaceuticals seem distant. But the core question this survey investigates is directly relevant to regulatory science: when an AI artifact trained in one context is deployed in another, what must be re-validated?

When an imaging AI trained on one disease is applied to another, evaluators must assess which characteristics of the training data carry over and where the model breaks down. Just as a game AI's performance changes when the control scheme or engine interface changes, a diagnostic AI's performance changes when the patient population or measurement conditions change. The parallel is structural, not superficial.

The six-role framework also offers an indirect lesson. In pharmaceutical AI, roles are similarly diverse: drug discovery, clinical trial design, safety signal detection, regulatory document generation, and post-marketing surveillance all use AI differently. Each role has its own data, its own evaluation standards, and its own transferability constraints. A survey that maps these roles with the same rigor applied here, asking what transfers and what does not, would be valuable for the pharmaceutical field.

The survey's approach of separating transferable capabilities from context-dependent ones, role by role, is a framework that could inform risk assessment when introducing AI into healthcare and regulatory settings. Game-domain insights do not translate directly into regulatory documentation. The connection is conceptual, useful as a reference rather than a prescription.